BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Cantaloupe, EyePoint, F45 Training, and PROG and Encourages Investors to Contact the Firm
26 oct. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cantaloupe, Inc. (NASDAQ:...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating EyePoint, Spectrum, F45, and PROG and Encourages Investors to Contact the Firm
16 oct. 2022 23h09 HE | Bragar Eagel & Squire
NEW YORK, Oct. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against EyePoint Pharmaceuticals,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating EyePoint, Spectrum, and F45 and Encourages Investors to Contact the Firm
11 oct. 2022 21h58 HE | Bragar Eagel & Squire
NEW YORK, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against EyePoint Pharmaceuticals,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Compass, EyePoint, F45, and PROG and Encourages Investors to Contact the Firm
06 oct. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating GrafTech, EyePoint, Vintage Wine, and Flowserve and Encourages Investors to Contact the Firm
26 sept. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GrafTech International...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating GrafTech, Polished, EyePoint, and Vintage Wine and Encourages Investors to Contact the Firm
21 sept. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GrafTech International...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Clariant, Polished, Singularity, and EyePoint and Encourages Investors to Contact the Firm
16 sept. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clariant AG (OTCMKTS:...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating EyePoint, Olo, Cognyte, and the WWE and Encourages Investors to Contact the Firm
11 sept. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Sept. 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against EyePoint Pharmaceuticals,...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. Is Investigating Singularity, Phathom, EyePoint, and Olo and Encourages Investors to Contact the Firm
06 sept. 2022 21h15 HE | Bragar Eagel & Squire
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Singularity Future...
EyePoint Pharmaceuticals Shareholder News: Johnson Fistel Encourages EYPT Shareholders with Losses to Contact the Firm Regarding Investigation
31 août 2022 09h40 HE | Johnson Fistel, LLP
SAN DIEGO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether EyePoint Pharmaceuticals, Inc. (“EyePoint” or “the...